Delivery Order SPE2DB22D2206-SPE2DB23FJC99
Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,777.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg vials of the antifungal medication Ambisome. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency programs. No major subcontractors or set aside designations were identified. The delivery order was awarded under an indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $1,923.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg vials of the antifungal medication Ambisome. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 13, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No set aside designation or subcontractors were indicated. The brief period of performance suggests this delivery order was placed to...
- The Defense Logistics Agency awarded a $1,923.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg vials of the antifungal medication Ambisome. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 13, 2023 in support of the Defense Logistics Agency's medical supply needs. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested Ambisome vials from its corporate distribution...
- Amerisourcebergen Drug Corporation, under its parent company Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $1,923 against the Defense Logistics Agency's prime vendor contract to supply 50 mg vials of the antifungal medication Ambisome. The firm fixed price order calls for delivery to a location in Conshohocken, Pennsylvania by June 27, 2023 to support the Defense Logistics Agency and Department of Defense supply chain. No subcontractors or set aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA). The $1,923.48 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range...
- The federal contract award is for the supply of AMBISOME 50 MG VIALS by Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to the Defense Logistics Agency (DLA). This is a firm fixed price delivery order with a potential value of $2,656.17 and a completion date of January 17, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken, Pennsylvania. No set-aside designation...
- <p>The Defense Logistics Agency issued a $4,661.14 delivery order to Amerisourcebergen Drug Corp on May 26, 2026, for Ambisome 50 mg vials, with ultimate completion on May 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside. The source does not identify the parent indefinite delivery contract vehicle by name or provide a period of performance beyond the completion date.</p>
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJC99Delivery Order
The Defense Logistics Agency awarded a $1,923.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg vials of the antifungal medication Ambisome. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the products from its Conshohocken, Pennsylvania location to fulfill requirements under the delivery order. The Defense Logistics Agency routinely issues delivery orders against its Prime Vendor contracts to supply medical products to various Department of Defense customers and treatment facilities. No subcontractors or set aside designations were identified for this particular order.
Generated 12/18/23, 7:27 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/12/23 |